Munich, Germany

Isabella Baum

This inventor holds 1 USPTO granted patent. Top assignee: Amoena Medizin-Orthopadie-Technik Gmbh. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Isabella Baum - Innovator in Breast Prosthesis Technology

Introduction

Isabella Baum is a notable inventor based in Munich, Germany. She has made significant contributions to the field of medical technology, particularly in the development of breast prostheses. Her innovative designs aim to enhance the quality of life for individuals who have undergone breast surgery.

Latest Patents

Isabella holds a patent for a breast prosthesis that features a support shell housed within a fabric cover. This prosthesis includes one or more filling chambers located at the rear side, designed to accommodate filler material. Additionally, the breast prosthesis is equipped with a silicone shell positioned in front of the support shell, which can be removed from the fabric cover. This design not only provides comfort but also allows for customization.

Career Highlights

Isabella Baum is currently employed at Amoena Medizin-Orthopädie-Technik GmbH, a company renowned for its focus on breast care solutions. Her work has been instrumental in advancing the technology used in breast prostheses, making her a key figure in the industry.

Collaborations

Isabella collaborates with talented professionals such as Michaela Reusch and Helmut F. Wild. Their combined expertise contributes to the innovative projects at Amoena, fostering an environment of creativity and advancement in medical technology.

Conclusion

Isabella Baum's contributions to breast prosthesis technology exemplify her commitment to improving patient care. Her innovative designs and collaborative efforts continue to make a positive impact in the field of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…